Press Release: Enhabit Home Health & Hospice Announces Date of 2025 Fourth Quarter Earnings Call

Dow Jones
Feb 13
DALLAS--(BUSINESS WIRE)--February 12, 2026-- 

Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced it will report its financial results for the fourth quarter and fiscal year ended Dec. 31, 2025, on March 4, 2026, and host a webcast and conference call on March 5, 2026. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time.

   --  March 5, 2026 
 
   --  9 a.m. EST 
 
   --  Toll-free: 888-660-6150 
 
   --  International: 929-203-0843 
 
   --  Conference ID: 5248158 
 
   --  Webcast link: https://events.q4inc.com/attendee/846254002 

A link to the webcast of the conference call and online replay can be found on Enhabit's investor website.

About Enhabit Home Health & Hospice

Enhabit Home Health & Hospice (Enhabit, Inc.) is a leading national home health and hospice provider working to expand what's possible for patient care in the home. Enhabit's team of clinicians supports patients and their families where they are most comfortable, with a nationwide footprint spanning 247 home health locations and 115 hospice locations across 34 states. Enhabit leverages advanced technology and compassionate teams to deliver extraordinary patient care. For more information, visit enhabit.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260212765203/en/

 
    CONTACT:    Investor relations contact 

Bob Okunski

investorrelations@ehab.com

469-860-6061

Media contact

Erin Volbeda

media@ehab.com

972-338-5141

 
 

(END) Dow Jones Newswires

February 12, 2026 17:24 ET (22:24 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10